Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥282.81 Million ≈ $41.38 Million USD) by net assets (CN¥9.60 Billion ≈ $1.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600521 equity financing ratio to measure how much of total assets are equity-financed.
Zhejiang Huahai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Huahai Pharmaceutical Co Ltd (600521) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Huahai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bluestar Adisseo Co
SHG:600299
|
0.048x |
|
Charoen Pokphand Foods Public Company Limited
F:NVAV
|
0.042x |
|
China Minsheng Banking Corp. Ltd
F:GHFH
|
-0.001x |
|
kakaopay Corp.
KO:377300
|
0.046x |
|
CECEP Wind-Power Corp Co Ltd
SHG:601016
|
0.092x |
|
Rubis SCA
PA:RUI
|
0.102x |
|
The a2 Milk Company Ltd
AU:A2M
|
0.069x |
|
Covivio Hotels
PA:COVH
|
0.035x |
Annual Cash Flow Conversion Efficiency for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Huahai Pharmaceutical Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.46 Billion ≈ $1.38 Billion |
CN¥1.23 Billion ≈ $180.00 Million |
0.130x | -45.99% |
| 2024-12-31 | CN¥9.02 Billion ≈ $1.32 Billion |
CN¥2.17 Billion ≈ $317.93 Million |
0.241x | -10.35% |
| 2023-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥2.22 Billion ≈ $324.42 Million |
0.269x | +67.47% |
| 2022-12-31 | CN¥7.75 Billion ≈ $1.13 Billion |
CN¥1.24 Billion ≈ $181.85 Million |
0.160x | +15.85% |
| 2021-12-31 | CN¥6.78 Billion ≈ $991.59 Million |
CN¥938.43 Million ≈ $137.32 Million |
0.138x | -40.13% |
| 2020-12-31 | CN¥6.72 Billion ≈ $983.95 Million |
CN¥1.56 Billion ≈ $227.61 Million |
0.231x | -23.78% |
| 2019-12-31 | CN¥5.78 Billion ≈ $845.61 Million |
CN¥1.75 Billion ≈ $256.66 Million |
0.304x | +1780.57% |
| 2018-12-31 | CN¥4.21 Billion ≈ $615.58 Million |
CN¥67.90 Million ≈ $9.94 Million |
0.016x | -85.06% |
| 2017-12-31 | CN¥5.05 Billion ≈ $739.67 Million |
CN¥546.24 Million ≈ $79.93 Million |
0.108x | +14.22% |
| 2016-12-31 | CN¥4.58 Billion ≈ $669.88 Million |
CN¥433.10 Million ≈ $63.38 Million |
0.095x | +80.21% |
| 2015-12-31 | CN¥3.72 Billion ≈ $544.40 Million |
CN¥195.31 Million ≈ $28.58 Million |
0.052x | -47.82% |
| 2014-12-31 | CN¥3.27 Billion ≈ $477.93 Million |
CN¥328.61 Million ≈ $48.09 Million |
0.101x | -38.04% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.82 Million |
CN¥490.29 Million ≈ $71.75 Million |
0.162x | +29.80% |
| 2012-12-31 | CN¥1.95 Billion ≈ $285.21 Million |
CN¥243.83 Million ≈ $35.68 Million |
0.125x | -3.12% |
| 2011-12-31 | CN¥1.53 Billion ≈ $223.82 Million |
CN¥197.51 Million ≈ $28.90 Million |
0.129x | -43.15% |
| 2010-12-31 | CN¥1.32 Billion ≈ $192.92 Million |
CN¥299.47 Million ≈ $43.82 Million |
0.227x | -13.25% |
| 2009-12-31 | CN¥1.21 Billion ≈ $177.39 Million |
CN¥317.44 Million ≈ $46.45 Million |
0.262x | +243.02% |
| 2008-12-31 | CN¥1.10 Billion ≈ $161.41 Million |
CN¥84.20 Million ≈ $12.32 Million |
0.076x | -45.45% |
| 2007-12-31 | CN¥975.52 Million ≈ $142.75 Million |
CN¥136.52 Million ≈ $19.98 Million |
0.140x | +57.99% |
| 2006-12-31 | CN¥875.40 Million ≈ $128.10 Million |
CN¥77.54 Million ≈ $11.35 Million |
0.089x | +33.34% |
| 2005-12-31 | CN¥802.34 Million ≈ $117.41 Million |
CN¥53.30 Million ≈ $7.80 Million |
0.066x | -68.13% |
| 2004-12-31 | CN¥785.53 Million ≈ $114.95 Million |
CN¥163.73 Million ≈ $23.96 Million |
0.208x | +201.31% |
| 2003-12-31 | CN¥685.42 Million ≈ $100.30 Million |
CN¥47.41 Million ≈ $6.94 Million |
0.069x | -92.60% |
| 2002-12-31 | CN¥80.56 Million ≈ $11.79 Million |
CN¥75.34 Million ≈ $11.02 Million |
0.935x | +79.90% |
| 2001-12-31 | CN¥72.15 Million ≈ $10.56 Million |
CN¥37.51 Million ≈ $5.49 Million |
0.520x | -- |
About Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and pol… Read more